Researchers performed a systematic review of PubMed literature until May2020 including clinical sequencing studies that utilized next-generation sequencing (NGS) in individuals with epilepsy, autism spectrum disorder (ASD), or intellectual disability (ID).
This study aimed to evaluate changes in sleep during the COVID-19 outbreak, and used data-driven approaches to identify distinct profiles of changes in sleep-related behaviors. Demographic, behavioral and psychological factors associated with sleep changes were also investigated.
When treating a patient with peripheral neuropathy and weakness of unknown origin, it is important for primary care providers to consider Charcot-Marie-Tooth disease as a differential diagnosis.
A smartphone application delivering guided progressive muscle relaxation was a both an accessible and acceptable form of therapy for patients with migraine.
Cognitive behavioral therapy is the first line treatment for insomnia, but studies have reported potential negative effects. This review aims to understand the extent to which adverse events are monitored for and reported in trial literature.
Patients with fibromyalgia suffer from chronic pain, which limits physical activity and is associated with disturbed sleep. However, the relationship between physical activity, pain, and sleep is unclear.
The guidelines were developed by a multidisciplinary panel led by the Infectious Diseases Society of America, the American Academy of Neurology, and the American College of Rheumatology.
Study authors identified and evaluated a statistical signal for an increased risk of Guillain-Barré Syndrome in days 1-42 after 2018-2019 high-dose influenza vaccine administration.
Neuropathological changes in patients with coronavirus disease 2019 are relatively mild, with neuroinflammatory changes in the brain stem most often found.
Although the cause of Alzheimer disease is not clear, recent advances in research have furthered the understanding of Alzheimer dementia as a continuum.
This study addresses possible consequences of the COVID-19 crisis and home confinement on maternal anxiety, maternal insomnia, and maternal reports of sleep problems among children aged 6–72 months.
